Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cancer Tissue Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Tissue Diagnosticsmarket, defines the market attractiveness level of Cancer Tissue Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Tissue Diagnostics industry, describes the types of Cancer Tissue Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Tissue Diagnostics market and the development prospects and opportunities of Cancer Tissue Diagnostics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Tissue Diagnostics market in Chapter 13.
By Player:
Bio Rad Laboratories Inc
Cancer Genetics Inc
Agilent Technologies and Inc
Enzo Life Sciences Inc
F Hoffmann-La Roche Ltd
Abbott
Danaher Corporation
Thermo Fisher Scientific Inc
Abcam plc
Merck KGaA (Sigma-Aldrich Co LLC)
By Type:
Immunohistochemistry (IHC) Test
In Situ Hybridisation Test
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Tissue Diagnostics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Tissue Diagnostics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Tissue Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Tissue Diagnostics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Tissue Diagnostics Market Analysis and Outlook to 2022
-
7.1 Global Cancer Tissue Diagnostics Consumption (2017-2022)
-
7.2 United States Cancer Tissue Diagnostics Consumption (2017-2022)
-
7.3 Europe Cancer Tissue Diagnostics Consumption (2017-2022)
-
7.4 China Cancer Tissue Diagnostics Consumption (2017-2022)
-
7.5 Japan Cancer Tissue Diagnostics Consumption (2017-2022)
-
7.6 India Cancer Tissue Diagnostics Consumption (2017-2022)
-
7.7 South Korea Cancer Tissue Diagnostics Consumption (2017-2022)
8 Region and Country-wise Cancer Tissue Diagnostics Market Analysis and Outlook to 2028
-
8.1 Global Cancer Tissue Diagnostics Consumption Forecast (2022-2028)
-
8.2 United States Cancer Tissue Diagnostics Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Tissue Diagnostics Consumption Forecast (2022-2028)
-
8.4 China Cancer Tissue Diagnostics Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Tissue Diagnostics Consumption Forecast (2022-2028)
-
8.6 India Cancer Tissue Diagnostics Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Tissue Diagnostics Consumption Forecast (2022-2028)
9 Global Cancer Tissue Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Tissue Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Immunohistochemistry (IHC) Test Consumption and Growth Rate (2017-2022)
-
9.1.2 Global In Situ Hybridisation Test Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Tissue Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Cancer Tissue Diagnostics Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Tissue Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Immunohistochemistry (IHC) Test Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global In Situ Hybridisation Test Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Tissue Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Tissue Diagnostics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Tissue Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Tissue Diagnostics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Tissue Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Tissue Diagnostics Market Competitive Analysis
-
14.1 Bio Rad Laboratories Inc
-
14.1.1 Bio Rad Laboratories Inc Company Details
-
14.1.2 Bio Rad Laboratories Inc Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bio Rad Laboratories Inc Cancer Tissue Diagnostics Product and Service
-
14.2 Cancer Genetics Inc
-
14.2.1 Cancer Genetics Inc Company Details
-
14.2.2 Cancer Genetics Inc Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Cancer Genetics Inc Cancer Tissue Diagnostics Product and Service
-
14.3 Agilent Technologies and Inc
-
14.3.1 Agilent Technologies and Inc Company Details
-
14.3.2 Agilent Technologies and Inc Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Agilent Technologies and Inc Cancer Tissue Diagnostics Product and Service
-
14.4 Enzo Life Sciences Inc
-
14.4.1 Enzo Life Sciences Inc Company Details
-
14.4.2 Enzo Life Sciences Inc Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Enzo Life Sciences Inc Cancer Tissue Diagnostics Product and Service
-
14.5 F Hoffmann-La Roche Ltd
-
14.5.1 F Hoffmann-La Roche Ltd Company Details
-
14.5.2 F Hoffmann-La Roche Ltd Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 F Hoffmann-La Roche Ltd Cancer Tissue Diagnostics Product and Service
-
14.6 Abbott
-
14.6.1 Abbott Company Details
-
14.6.2 Abbott Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Abbott Cancer Tissue Diagnostics Product and Service
-
14.7 Danaher Corporation
-
14.7.1 Danaher Corporation Company Details
-
14.7.2 Danaher Corporation Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Danaher Corporation Cancer Tissue Diagnostics Product and Service
-
14.8 Thermo Fisher Scientific Inc
-
14.8.1 Thermo Fisher Scientific Inc Company Details
-
14.8.2 Thermo Fisher Scientific Inc Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Thermo Fisher Scientific Inc Cancer Tissue Diagnostics Product and Service
-
14.9 Abcam plc
-
14.9.1 Abcam plc Company Details
-
14.9.2 Abcam plc Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Abcam plc Cancer Tissue Diagnostics Product and Service
-
14.10 Merck KGaA (Sigma-Aldrich Co LLC)
-
14.10.1 Merck KGaA (Sigma-Aldrich Co LLC) Company Details
-
14.10.2 Merck KGaA (Sigma-Aldrich Co LLC) Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Merck KGaA (Sigma-Aldrich Co LLC) Cancer Tissue Diagnostics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Tissue Diagnostics
-
Figure Cancer Tissue Diagnostics Picture
-
Table Global Cancer Tissue Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Tissue Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Tissue Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Tissue Diagnostics Consumption by Country (2017-2022)
-
Figure United States Cancer Tissue Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Tissue Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Tissue Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Tissue Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Tissue Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Tissue Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Tissue Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Tissue Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Tissue Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Tissue Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Tissue Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Tissue Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Tissue Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunohistochemistry (IHC) Test Consumption and Growth Rate (2017-2022)
-
Figure Global In Situ Hybridisation Test Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Immunohistochemistry (IHC) Test Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global In Situ Hybridisation Test Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Tissue Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Tissue Diagnostics Export by Region (Top 5 Countries) (2017-2028)
-
Table Bio Rad Laboratories Inc (Foundation Year, Company Profile and etc.)
-
Table Bio Rad Laboratories Inc Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio Rad Laboratories Inc Cancer Tissue Diagnostics Product and Service
-
Table Cancer Genetics Inc (Foundation Year, Company Profile and etc.)
-
Table Cancer Genetics Inc Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cancer Genetics Inc Cancer Tissue Diagnostics Product and Service
-
Table Agilent Technologies and Inc (Foundation Year, Company Profile and etc.)
-
Table Agilent Technologies and Inc Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent Technologies and Inc Cancer Tissue Diagnostics Product and Service
-
Table Enzo Life Sciences Inc (Foundation Year, Company Profile and etc.)
-
Table Enzo Life Sciences Inc Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enzo Life Sciences Inc Cancer Tissue Diagnostics Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Cancer Tissue Diagnostics Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Cancer Tissue Diagnostics Product and Service
-
Table Danaher Corporation (Foundation Year, Company Profile and etc.)
-
Table Danaher Corporation Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Danaher Corporation Cancer Tissue Diagnostics Product and Service
-
Table Thermo Fisher Scientific Inc (Foundation Year, Company Profile and etc.)
-
Table Thermo Fisher Scientific Inc Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Inc Cancer Tissue Diagnostics Product and Service
-
Table Abcam plc (Foundation Year, Company Profile and etc.)
-
Table Abcam plc Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abcam plc Cancer Tissue Diagnostics Product and Service
-
Table Merck KGaA (Sigma-Aldrich Co LLC) (Foundation Year, Company Profile and etc.)
-
Table Merck KGaA (Sigma-Aldrich Co LLC) Cancer Tissue Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck KGaA (Sigma-Aldrich Co LLC) Cancer Tissue Diagnostics Product and Service
-
